These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 27718447)

  • 21. B-lymphocyte depletion therapy in rheumatoid arthritis and other autoimmune disorders.
    Edwards JC; Leandro MJ; Cambridge G
    Biochem Soc Trans; 2002 Aug; 30(4):824-8. PubMed ID: 12196207
    [TBL] [Abstract][Full Text] [Related]  

  • 22. B-cell-directed therapy for inflammatory skin diseases.
    Nagel A; Hertl M; Eming R
    J Invest Dermatol; 2009 Feb; 129(2):289-301. PubMed ID: 19148218
    [TBL] [Abstract][Full Text] [Related]  

  • 23. B cell targeted therapies in autoimmune disease.
    Barnas JL; Looney RJ; Anolik JH
    Curr Opin Immunol; 2019 Dec; 61():92-99. PubMed ID: 31733607
    [TBL] [Abstract][Full Text] [Related]  

  • 24. B cell depletion therapy in autoimmune diseases.
    Sanz I; Anolik JH; Looney RJ
    Front Biosci; 2007 Jan; 12():2546-67. PubMed ID: 17127262
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ocrelizumab: a step forward in the evolution of B-cell therapy.
    Kausar F; Mustafa K; Sweis G; Sawaqed R; Alawneh K; Salloum R; Badaracco M; Niewold TB; Sweiss NJ
    Expert Opin Biol Ther; 2009 Jul; 9(7):889-95. PubMed ID: 19463076
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Does B cell depletion have a role to play in the treatment of systemic lupus erythematosus?
    Gorman C; Leandro M; Isenberg D
    Lupus; 2004; 13(5):312-6. PubMed ID: 15230284
    [TBL] [Abstract][Full Text] [Related]  

  • 27. B cell-targeted therapy with rituximab and autoimmune neuromuscular disorders.
    Stübgen JP
    J Neuroimmunol; 2008 Nov; 204(1-2):1-12. PubMed ID: 18783837
    [TBL] [Abstract][Full Text] [Related]  

  • 28. B cells as a therapeutic target in autoimmune disease.
    Goronzy JJ; Weyand CM
    Arthritis Res Ther; 2003; 5(3):131-5. PubMed ID: 12723978
    [TBL] [Abstract][Full Text] [Related]  

  • 29. B lymphocytes in systemic lupus erythematosus: lessons from therapy targeting B cells.
    Looney RJ; Anolik J; Sanz I
    Lupus; 2004; 13(5):381-90. PubMed ID: 15230297
    [TBL] [Abstract][Full Text] [Related]  

  • 30. B cell depletion in autoimmune rheumatic diseases.
    Pitashny M; Shoenfeld Y
    Autoimmun Rev; 2005 Sep; 4(7):436-41. PubMed ID: 16137609
    [TBL] [Abstract][Full Text] [Related]  

  • 31. B cells as a therapeutic target in autoimmune diseases other than rheumatoid arthritis.
    Looney RJ
    Rheumatology (Oxford); 2005 May; 44 Suppl 2():ii13-ii17. PubMed ID: 15851522
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SLE - Rituximab in lupus.
    Eisenberg R
    Arthritis Res Ther; 2003; 5(4):157-9. PubMed ID: 12823844
    [TBL] [Abstract][Full Text] [Related]  

  • 33. B-cell: a logical target for treatment of rheumatoid arthritis.
    Youinou P; Jamin C; Saraux A
    Clin Exp Rheumatol; 2007; 25(2):318-28. PubMed ID: 17543163
    [TBL] [Abstract][Full Text] [Related]  

  • 34. T cell targeted immunotherapy for autoimmune disease.
    Lee E; Sinha AA
    Autoimmunity; 2005 Dec; 38(8):577-96. PubMed ID: 16390811
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeting B cells and autoantibodies in the therapy of autoimmune diseases.
    Kao D; Lux A; Schwab I; Nimmerjahn F
    Semin Immunopathol; 2014 May; 36(3):289-99. PubMed ID: 24777745
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rituximab-induced B cell depletion in autoimmune diseases: potential effects on T cells.
    Liossis SN; Sfikakis PP
    Clin Immunol; 2008 Jun; 127(3):280-5. PubMed ID: 18337174
    [TBL] [Abstract][Full Text] [Related]  

  • 37. B cell-targeted immunotherapy for type 1 diabetes: What can make it work?
    Hamad AR; Ahmed R; Donner T; Fousteri G
    Discov Med; 2016 Mar; 21(115):213-9. PubMed ID: 27115172
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-CD20 monoclonal antibodies: beyond B-cells.
    Avivi I; Stroopinsky D; Katz T
    Blood Rev; 2013 Sep; 27(5):217-23. PubMed ID: 23953071
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD20: a target antigen for immunotherapy of autoimmune diseases.
    Perosa F; Favoino E; Caragnano MA; Prete M; Dammacco F
    Autoimmun Rev; 2005 Nov; 4(8):526-31. PubMed ID: 16214090
    [TBL] [Abstract][Full Text] [Related]  

  • 40. B-lymphocyte contributions to human autoimmune disease.
    Yanaba K; Bouaziz JD; Matsushita T; Magro CM; St Clair EW; Tedder TF
    Immunol Rev; 2008 Jun; 223():284-99. PubMed ID: 18613843
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.